BACKGROUND/AIMS: In vivo autofluorescence endoscopic imaging and spectroscopy have been used to detect and differentiate benign (hyperplastic) and preneoplastic (adenomatous) colonic lesions. This fluorescence is composed of contributions from the epithelium, lamina propria, and submucosa. Because epithelial autofluorescence in normal and diseased tissues is poorly understood, this was the focus of the present study. METHODS: Whole colonic crypts were isolated, and short term primary cultures of epithelial cells were established from biopsies of normal, hyperplastic, and adenomatous colon. Autofluorescence (488 nm excitation) was examined by confocal fluorescence microscopy. Fluorescently labelled organelle probes and transmission electron microscopy were used to identify subcellular sources of fluorescence. RESULTS: Mitochondria and lysosomes were identified as the main intracellular fluorescent components in all cell types. Normal and hyperplastic epithelial cells were weakly autofluorescent and had similar numbers of mitochondria and lysosomes, whereas adenomatous (dysplastic) epithelial cells showed much higher autofluorescence, and numerous highly autofluorescent lysosomal (lipofuscin) granules. CONCLUSIONS: Short term primary cell cultures from endoscopic biopsies provide a novel model to understand differences in colonic tissue autofluorescence at the glandular (crypt) and cellular levels. The differences between normal, hyperplastic, and adenomatous epithelial cells are attributed in part to differences in the intrinsic numbers of mitochondria and lysosomes. This suggests that the detection of colonic epithelial fluorescence alone, if possible, may be sufficient to differentiate benign (hyperplastic) from preneoplastic and neoplastic (adenomatous) colonic intramucosal lesions during in vivo fluorescence endoscopy. Furthermore, highly orange/red autofluorescent intracellular granules found only in dysplastic epithelial cells may serve as a potential biomarker.
BACKGROUND/AIMS: In vivo autofluorescence endoscopic imaging and spectroscopy have been used to detect and differentiate benign (hyperplastic) and preneoplastic (adenomatous) colonic lesions. This fluorescence is composed of contributions from the epithelium, lamina propria, and submucosa. Because epithelial autofluorescence in normal and diseased tissues is poorly understood, this was the focus of the present study. METHODS: Whole colonic crypts were isolated, and short term primary cultures of epithelial cells were established from biopsies of normal, hyperplastic, and adenomatous colon. Autofluorescence (488 nm excitation) was examined by confocal fluorescence microscopy. Fluorescently labelled organelle probes and transmission electron microscopy were used to identify subcellular sources of fluorescence. RESULTS: Mitochondria and lysosomes were identified as the main intracellular fluorescent components in all cell types. Normal and hyperplastic epithelial cells were weakly autofluorescent and had similar numbers of mitochondria and lysosomes, whereas adenomatous (dysplastic) epithelial cells showed much higher autofluorescence, and numerous highly autofluorescent lysosomal (lipofuscin) granules. CONCLUSIONS: Short term primary cell cultures from endoscopic biopsies provide a novel model to understand differences in colonic tissue autofluorescence at the glandular (crypt) and cellular levels. The differences between normal, hyperplastic, and adenomatous epithelial cells are attributed in part to differences in the intrinsic numbers of mitochondria and lysosomes. This suggests that the detection of colonic epithelial fluorescence alone, if possible, may be sufficient to differentiate benign (hyperplastic) from preneoplastic and neoplastic (adenomatous) colonic intramucosal lesions during in vivo fluorescence endoscopy. Furthermore, highly orange/red autofluorescent intracellular granules found only in dysplastic epithelial cells may serve as a potential biomarker.
Authors: J Haringsma; G N Tytgat; H Yano; H Iishi; M Tatsuta; T Ogihara; H Watanabe; N Sato; N Marcon; B C Wilson; R W Cline Journal: Gastrointest Endosc Date: 2001-05 Impact factor: 9.427
Authors: R Drezek; C Brookner; I Pavlova; I Boiko; A Malpica; R Lotan; M Follen; R Richards-Kortum Journal: Photochem Photobiol Date: 2001-06 Impact factor: 3.421
Authors: L M Perriott; T Kono; R R Whitesell; S M Knobel; D W Piston; D K Granner; A C Powers; J M May Journal: Am J Physiol Endocrinol Metab Date: 2001-07 Impact factor: 4.310
Authors: Jurjen Emmelkamp; Floor Wolbers; Helene Andersson; Ralph S Dacosta; Brian C Wilson; Istvan Vermes; Albert van den Berg Journal: Electrophoresis Date: 2004-11 Impact factor: 3.535
Authors: Ralf Kiesslich; Juergen Burg; Michael Vieth; Janina Gnaendiger; Meike Enders; Peter Delaney; Adrian Polglase; Wendy McLaren; Daniela Janell; Steven Thomas; Bernhard Nafe; Peter R Galle; Markus F Neurath Journal: Gastroenterology Date: 2004-09 Impact factor: 22.682
Authors: Obrad R Sćepanović; Zoya Volynskaya; Chae-Ryon Kong; Luis H Galindo; Ramachandra R Dasari; Michael S Feld Journal: Rev Sci Instrum Date: 2009-04 Impact factor: 1.523
Authors: Ditsa Levanon; Yael Bernstein; Varda Negreanu; Karen Rae Bone; Amir Pozner; Raya Eilam; Joseph Lotem; Ori Brenner; Yoram Groner Journal: EMBO Mol Med Date: 2011-08-08 Impact factor: 12.137
Authors: Jonas Wizenty; Teresa Schumann; Donna Theil; Martin Stockmann; Johann Pratschke; Frank Tacke; Felix Aigner; Tilo Wuensch Journal: Molecules Date: 2020-04-30 Impact factor: 4.411
Authors: Kai Yang; Sara Fard; Rudolf Furrer; Michael C Archer; W Robert Bruce; HoYin Lip; Rhea Mehta; Peter J O'Brien; Adria Giacca; Wendy E Ward; A Pietro Femia; Giovanna Caderni; Alan Medline; Kate Banks Journal: Nutr Cancer Date: 2015-12-28 Impact factor: 2.900